Patrick J. McEnany, President and CEO at CATALYST PHARMACEUTICALS, INC. (CPRX), bought 20,000 shares at $2.29 ($46K) on 2018-04-03, disclosed to the SEC on 2018-04-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CPRX | SELL | 2024-11-15 | $4.1M | — | Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |